愛康科技(002610.SZ):控股股東所持3292萬股解除輪候凍結 實控人所持1.17億股被輪候凍結
格隆匯 7 月 29日丨愛康科技(002610.SZ)公佈,公司經查詢中國證券登記結算有限責任公司深圳分公司證券輪候凍結數據表,獲悉公司控股股東江蘇愛康實業集團有限公司(“愛康實業”)所持有的公司部分股份解除輪候凍結,實際控制人鄒承慧所持有的公司部分股份被輪候凍結。其中,愛康實業所持3292萬股解除輪候凍結,佔其所持股份比例5.19%;鄒承慧所持1.17億股被輪候凍結,佔其所持股份比例95.90%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.